Showing results (201-210 of 315) with videos related to
Sort By:
Pageof 32
Medical and Pediatric Oncology|January 1, 1989
Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignanciesN P Christiansen, B J Kennedy, A C Ochoa, et al.International Archives of Allergy and Immunology|April 1, 1995
Role of endothelial cells in transplantationS C Robson, D Candinas, W W Hancock, et al.The Journal of Surgical Research|April 1, 1984
Rejection of established mouse pancreatic islet allografts by active immunization requires class I (H-2 K, D) antigen disparitiesC E Morrow, D E Sutherland, M W Steffes, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitroL K Chen, D Mathieu-Mahul, F H Bach, et al.Clinical Transplantation|February 1, 1996
Genetic engineering of endothelial cells to ameliorate xenograft rejectionF H Bach, S C Robson, C J Wrighton, et al.Immunology Today|November 1, 1992
Candidate natural killer cell receptorsE Hofer, M Düchler, S A Fuad, et al.Science (New York, N.Y.)|March 18, 1983
H-2 antigen class: effect on mouse islet allograft rejectionC E Morrow, D E Sutherland, M W Steffes, et al.European Journal of Immunology|November 1, 1991
The role of C5a and antibody in the release of heparan sulfate from endothelial cellsJ L Platt, A P Dalmasso, B J Lindman, et al.Advances in Experimental Medicine and Biology|January 1, 1997
Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitorsD S Cross, J L Platt, S K Juhn, et al.Pageof 32